215 related articles for article (PubMed ID: 26514359)
21. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management.
Catapano D; Muscarella LA; Guarnieri V; Zelante L; D'Angelo VA; D'Agruma L
Neurosurgery; 2005 Jun; 56(6):1215-21; discussion 1221. PubMed ID: 15918937
[TBL] [Abstract][Full Text] [Related]
22. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM
Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686
[TBL] [Abstract][Full Text] [Related]
23. Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas.
Merrill MJ; Edwards NA; Lonser RR
J Neurosurg; 2011 Sep; 115(3):512-7. PubMed ID: 21663414
[TBL] [Abstract][Full Text] [Related]
24. A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis.
Luo F; Sun B; Li H; Xu Y; Liu Y; Liu X; Lu L; Li J; Wang Q; Wei S; Shi L; Lu X; Liu Q; Zhang A
Oncotarget; 2016 Feb; 7(5):5769-87. PubMed ID: 26735578
[TBL] [Abstract][Full Text] [Related]
25. Whole exome sequencing identified genetic variations in Chinese hemangioblastoma patients.
Ma D; Yang J; Wang Y; Huang X; Du G; Zhou L
Am J Med Genet A; 2017 Oct; 173(10):2605-2613. PubMed ID: 28742274
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.
Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M
Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148
[TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas.
Toledo RA; Qin Y; Srikantan S; Morales NP; Li Q; Deng Y; Kim SW; Pereira MA; Toledo SP; Su X; Aguiar RC; Dahia PL
Endocr Relat Cancer; 2013 Jun; 20(3):349-59. PubMed ID: 23533246
[TBL] [Abstract][Full Text] [Related]
28. Endothelial cells by inactivation of VHL gene direct angiogenesis, not vasculogenesis via Twist1 accumulation associated with hemangioblastoma neovascularization.
Wang Y; Chen DQ; Chen MY; Ji KY; Ma DX; Zhou LF
Sci Rep; 2017 Jul; 7(1):5463. PubMed ID: 28710479
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effects respond to cerebral ischemia without susceptibility to HB-tumorigenesis in VHL heterozygous knockout mice.
Wang Y; Yang J; Du G; Ma D; Zhou L
Mol Carcinog; 2017 Oct; 56(10):2342-2351. PubMed ID: 28574654
[TBL] [Abstract][Full Text] [Related]
30. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
[TBL] [Abstract][Full Text] [Related]
31. Erythrocytosis associated with a novel missense mutation in the HIF2A gene.
van Wijk R; Sutherland S; Van Wesel AC; Huizinga EG; Percy MJ; Bierings M; Lee FS
Haematologica; 2010 May; 95(5):829-32. PubMed ID: 20007141
[TBL] [Abstract][Full Text] [Related]
32. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
[TBL] [Abstract][Full Text] [Related]
33. Nonmosaic somatic HIF2A mutations associated with late onset polycythemia-paraganglioma syndrome: Newly recognized subclass of polycythemia-paraganglioma syndrome.
Pang Y; Gupta G; Jha A; Yue X; Wang H; Huynh TT; Li A; Li L; Baker E; Chew E; Feelders RA; Korpershoek E; Zhuang Z; Yang C; Pacak K
Cancer; 2019 Apr; 125(8):1258-1266. PubMed ID: 30644531
[TBL] [Abstract][Full Text] [Related]
34. Sporadic hemangioblastomas are characterized by cryptic VHL inactivation.
Shankar GM; Taylor-Weiner A; Lelic N; Jones RT; Kim JC; Francis JM; Abedalthagafi M; Borges LF; Coumans JV; Curry WT; Nahed BV; Shin JH; Paek SH; Park SH; Stewart C; Lawrence MS; Cibulskis K; Thorner AR; Van Hummelen P; Stemmer-Rachamimov AO; Batchelor TT; Carter SL; Hoang MP; Santagata S; Louis DN; Barker FG; Meyerson M; Getz G; Brastianos PK; Cahill DP
Acta Neuropathol Commun; 2014 Dec; 2():167. PubMed ID: 25589003
[TBL] [Abstract][Full Text] [Related]
35. Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases.
Weil RJ; Vortmeyer AO; Zhuang Z; Pack SD; Theodore N; Erickson RK; Oldfield EH
J Neurosurg; 2002 Apr; 96(4):775-87. PubMed ID: 11990821
[TBL] [Abstract][Full Text] [Related]
36. Clinical features of patients bearing central nervous system hemangioblastoma in von Hippel-Lindau disease.
Kanno H; Kuratsu J; Nishikawa R; Mishima K; Natsume A; Wakabayashi T; Houkin K; Terasaka S; Shuin T
Acta Neurochir (Wien); 2013 Jan; 155(1):1-7. PubMed ID: 23080552
[TBL] [Abstract][Full Text] [Related]
37. Molecular dissection of the VHL gene in solitary capillary hemangioblastoma of the central nervous system.
Muscarella LA; la Torre A; Faienza A; Catapano D; Bisceglia M; D'Angelo V; Parrella P; Coco M; Fini G; Tancredi A; Zelante L; Fazio VM; D'Agruma L
J Neuropathol Exp Neurol; 2014 Jan; 73(1):50-8. PubMed ID: 24335534
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups.
Woltering N; Albers A; Müther M; Stummer W; Paulus W; Hasselblatt M; Holling M; Thomas C
Brain Pathol; 2022 Nov; 32(6):e13083. PubMed ID: 35637626
[TBL] [Abstract][Full Text] [Related]
39. [Genetics and angiogenesis: the example of von Hippel-Lindau disease].
Richard S; Ladroue C; Gad S; Giraud S; Gardie B;
Bull Cancer; 2007 Jul; 94 Spec No():S170-9. PubMed ID: 17846002
[TBL] [Abstract][Full Text] [Related]
40. Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.
Morris MR; Hughes DJ; Tian YM; Ricketts CJ; Lau KW; Gentle D; Shuib S; Serrano-Fernandez P; Lubinski J; Wiesener MS; Pugh CW; Latif F; Ratcliffe PJ; Maher ER
Anticancer Res; 2009 Nov; 29(11):4337-43. PubMed ID: 20032376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
